Researcher
Bénédicte Dubois
- Disciplines:Neurosciences
Affiliations
- Research Group Experimental Neurology (Division)
Responsible
From1 Feb 2014 → Today - Laboratory for Neuroimmunology (Lab)
Responsible
From1 Jan 2006 → Today - Laboratory for Neuroimmunology (Lab)
Member
From1 Jan 2012 → 31 Mar 2016 - Research Group Experimental Neurology (Division)
Member
From1 Oct 2003 → Today - Department of Neurosciences (Department)
Member
From1 Oct 2001 → 30 Sep 2003 - Immunobiology (Rega Institute) (Lab)
Member
From1 Oct 1999 → 30 Sep 2001
Projects
1 - 10 of 19
- Multiple sclerosis immunogenetics: moving to multimodal single-cell resolutionFrom1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- The role of natural killer cell subsets in the multiple sclerosis brainFrom1 Jan 2024 → TodayFunding: Private funding of national origin - undefined
- Multiple sclerosis immunogenetics.From1 Oct 2023 → 31 Mar 2024Funding: Own budget, for example: patrimony, inscription fees, gifts
- Identifying novel insights into molecular pathways that contribute to axonal loss in progressive multiple sclerosis.From1 Oct 2022 → TodayFunding: BOF - ZAP BOF mandates
- Elucidating the role of Epstein-Barr virus in multiple sclerosis pathophysiology.From1 Oct 2022 → TodayFunding: FWO fellowships
- The Role of Natural Killer Cells in Multiple SclerosisFrom1 Sep 2021 → TodayFunding: FWO fellowships
- Multiple sclerosis immunogenetics: moving to multi-omics single-cell resolutionFrom1 Sep 2021 → TodayFunding: FWO fellowships, Foreign private sponsor - undefined
- Inter-individual variation in susceptibility to and disease course of multiple sclerosisFrom1 Oct 2020 → 20 Apr 2024Funding: Own budget, for example: patrimony, inscription fees, gifts
- Somatic mutations leading to CD8+ T cell proliferation contribute to the pathogenesis of multiple sclerosisFrom1 Jan 2019 → 31 Dec 2022Funding: FWO research project (including WEAVE projects)
- Multiple sclerosis postdoctoral research fellowship Emanuela Oldoni.From5 Feb 2018 → 4 Feb 2020Funding: Foreign Nonprofit organisations and equivalents
Publications
31 - 40 of 100
- Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk(2018)
Authors: An Goris, Bénédicte Dubois, Robin Lemmens, Philip Van Damme
Pages: 1679 - 1695 - LncRNAs expression profile in peripheral blood mononuclear cells from multiple sclerosis patients(2018)
Authors: Emanuela Oldoni, An Goris, Bénédicte Dubois
Pages: 129 - 135 - Genetic Architecture of Adaptive Immune System Identifies Key Immune Regulators(2018)
Authors: Vasiliki Lagou, Ide Smets, Lies Van Horebeek, Marijne Vandebergh, Stephanie Humblet-Baron, Matthieu Moisse, Philip Van Damme, Guy Boeckxstaens, Bénédicte Dubois, James Dooley, et al.
Pages: 798 - + - The BELTRIMS registry: real-world safety and efficacy of DMTs in Belgium(2018)
Authors: Bénédicte Dubois
Pages: 920 - 920 - Heterogeneity in multiple sclerosis. Insights from imaging, immunology and genetics(2018)
Authors: Ide Smets, Bénédicte Dubois, An Goris, Adrian Liston
- A Belgian consensus protocol for autologous hematopoietic stem cell transplantation in multiple sclerosis(2018)
Authors: Ludo Vanopdenbosch, Bénédicte Dubois, Daan Dierickx
Pages: 161 - 168 - Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study(2018)
Authors: Ludwig Kappos, Amit Bar-Or, Bruce AC Cree, Robert J Fox, Gavin Giovannoni, Ralf Gold, Patrick Vermersch, Douglas L Arnold, Sophie Arnould, Tatiana Scherz, et al.
Pages: 1263 - 1273 - Management of immune thrombocytopenia in multiple sclerosis patients treated with alemtuzumab: a Belgian consensus (vol 118, pg 7, 2018)(2018)
Authors: Catherine Lambert, Bénédicte Dubois, Dominique Dive, Andreas Lysandropoulos, Dominik Selleslag, Ludo Vanopdenbosch, Vincent Van Pesch, Bart Vanwijmeersch, Ann Janssens
Pages: 141 - 141 - Management of immune thrombocytopenia in multiple sclerosis patients treated with alemtuzumab: a Belgian consensus(2018)
Authors: Bénédicte Dubois, Ludo Vanopdenbosch, Ann Janssens
Pages: 7 - 11 - Multiple sclerosis risk variants alter expression of co-stimulatory genes in B cells(2018)
Authors: Ide Smets, James Dooley, Stephanie Humblet-Baron, Bénédicte Dubois, Adrian Liston, An Goris
Pages: 786 - 796